How a Top 10 Global Pharma Unified Its Research Workflows with Positron

Summary

A global pharmaceutical company eliminated the "fragmentation tax" slowing its research and data science community by moving to Positron, giving R, Python, and AI users a single unified environment. To balance speed with regulatory rigor, the company runs two separate platforms: an exploratory environment for rapid innovation and a GXP platform for validated, audit-ready clinical reporting. Together, they've replaced manual copy-paste workflows with a streamlined, AI-assisted pipeline that generates clinical trial data significantly faster, while reducing overall platform costs in the process.

About:

Top 10 global pharmaceutical company

Industry:

Life Science

Technology used:

Posit Team, Positron

The challenge

Fragmented Data Science Environments

At a top 10 global pharmaceutical company, tackling the world's toughest health challenges requires modernizing clinical research to improve access and affordability to lifesaving treatments. To reach that goal, researchers need to move quickly and share findings across teams. For years, however, a "fragmentation tax" stood in the way of that collaboration.

The research and data science community was often siloed by the very tools meant to empower them. R users lived in RStudio, while Python developers worked in VS Code or Jupyter. This forced researchers to manage multiple interfaces to stay connected with their colleagues. The complexity was even higher for SAS programmers trying to adopt R or Python, they didn't just have to learn a new language, they had to master entirely different interfaces just to collaborate with their peers.

To further accelerate the path to new medical breakthroughs, the company recognized the value in moving toward a unified, multilingual environment: a single space where all researchers could thrive together.

Constant Context Switching

The challenge intensified in the summer of 2025 when the company set out to further accelerate clinical development with a new GenAI strategy. Leadership rolled out GitHub Copilot and Amazon Q to help researchers write and debug code with greater speed.

However, their introduction revealed a new technical bottleneck for the company's large community of R users. Amazon Q was designed as a powerful plugin for VS Code, leading to constant "context switching." Researchers would generate or troubleshoot code in VS Code, then copy and paste it back into RStudio to execute it against their data and refine the results. This friction slowed down their work and disrupted the flow of analysis. The need for an environment that could handle both high-level data science and modern AI extensions became more urgent than ever.

The solution

A Multilingual Future with Positron

When Positron launched in August 2025, the engineering team saw an immediate opportunity to consolidate their workflows. They moved with remarkable speed, transitioning from initial testing to an exploratory environment available for researchers in just two weeks.

Positron supports both R and Python users in one environment and, as a fork of VS Code, allows researchers to use the full ecosystem of VS Code extensions straight out of the box, while remaining in a familiar, high-performance data science environment. By unifying data scientists, application developers, and statisticians in a single IDE, the company eliminated the friction that had previously fragmented their talent.

Two-Track Infrastructure for Speed and Control

The company utilizes a two-track infrastructure that balances rapid innovation with rigorous control.

The exploratory platform is designed for the leading edge, prioritizing speed and innovation. The team can scale up to 20,000 concurrent cores for simulations and approve new R or Python packages within hours. This flexibility allowed them to deploy Positron and its AI capabilities almost immediately to meet researcher demand.

The GXP platform is built for regulatory submissions, where stability is paramount. It uses validated containers and rigorous documentation to ensure every analysis is reproducible for audits. Updates here follow a longer runway to maintain the standards required for official clinical reporting.

To keep rapid innovation audit-ready, the company uses a "3R" framework: Rebuild, Replicate, and Recover. This automated infrastructure ensures the team can show exactly how any result was reached, maintaining the high-trust environment required for clinical reporting.

The results

A Faster Path to Life-Changing Data

The company has fundamentally changed the speed of clinical insight by collapsing the wall between R and Python. The move to Positron has replaced manual copy-paste workflows with a streamlined, AI-assisted pipeline that generates clinical trial data significantly faster than previous methods.

Senior members of the Pharma R&D IT team point to a meaningful reduction in platform footprint, with direct cost savings to the bottom line that followed.

For this top 10 pharmaceutical, the technical win and the business win turned out to be the same thing: help researchers stop worrying about their tools and get back to thinking about their data.